Literature DB >> 16046704

Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels?

Krista A Varady1, Peter J H Jones.   

Abstract

At present, dyslipidemia is most commonly treated with drug therapy. However, because safety concerns regarding the use of pharmaceutical agents have arisen, a need for alternative nonpharmacological therapies has become increasingly apparent. The National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) recommends lifestyle therapies, which include a combination of diet and exercise modifications, in place of drug treatment for patients who fall into an intermediate range of coronary heart disease (CHD) risk. This review examined the cholesterol lowering efficacy of the following 2 NCEP-recommended combination therapies: 1) low saturated fat diets combined with exercise, and 2) nutritional supplementation, i.e., fish oil, oat bran, or plant sterol supplementation, combined with exercise, in the treatment of dyslipidemia. Combination therapies are particularly advantageous because diet and exercise elicit complementary effects on lipid profiles. More specifically, diet therapies, with some exceptions, lower total (TC) and LDL cholesterol (LDL-C) concentrations, whereas exercise interventions increase HDL cholesterol (HDL-C) while decreasing triglyceride (TG) levels. With respect to specific interventions, low saturated fat diets combined with exercise lowered TC, LDL-C, and TG concentrations by 7-18, 7-15, and 4-18%, respectively, while increasing HDL-C levels by 5-14%. Alternatively, nutritional supplements combined with exercise, decreased TC, LDL-C, and TG concentrations by 8-26, 8-30, and 12-39%, respectively, while increasing HDL-C levels by 2-8%. These findings suggest that combination lifestyle therapies are an efficacious, preliminary means of improving cholesterol levels in those diagnosed with dyslipidemia, and should be implemented in place of drug therapy when cholesterol levels fall just above the normal range.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046704     DOI: 10.1093/jn/135.8.1829

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  25 in total

Review 1.  Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.

Authors:  K Mahdy Ali; A Wonnerth; K Huber; J Wojta
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Ella R Jarvik; Elisabeth A Rosenthal; Thomas S Hatsukami; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

Review 3.  Vascular Disease in Young Indians (20-40 years): Role of Dyslipidemia.

Authors:  Jamshed Dalal; Pradeep Kumar Deb; Sameer Shrivastava; Maddury Srinivas Rao; Jagdish Chander Mohan; Arramraju Sreenivas Kumar
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 4.  Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review.

Authors:  Ying Jie Chee; Hian Hui Vincent Chan; Ngiap Chuan Tan
Journal:  Singapore Med J       Date:  2014-08       Impact factor: 1.858

Review 5.  Targeting inflammation in metabolic syndrome.

Authors:  Francine K Welty; Abdulhamied Alfaddagh; Tarec K Elajami
Journal:  Transl Res       Date:  2015-07-03       Impact factor: 7.012

6.  Lifestyle therapy changes and hypercholesterolemia: identifying risk groups in a community sample of Blacks and Whites.

Authors:  Rhonda BeLue; Stephanie T Lanza; M Kathleen Figaro
Journal:  Ethn Dis       Date:  2009       Impact factor: 1.847

7.  Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease.

Authors:  Y Bai; W Sigala; G R Adams; N D Vaziri
Journal:  Am J Nephrol       Date:  2008-09-17       Impact factor: 3.754

8.  Mixed Messages, Mixed Outcomes: Exposure to Direct-to-Consumer Advertising for Statin Drugs is Associated with More Frequent Visits to Fast Food Restaurants and Exercise.

Authors:  Jeff Niederdeppe; Rosemary J Avery; Maxwell D Kellogg; Alan Mathios
Journal:  Health Commun       Date:  2016-07-18

9.  Low-grade inflammation in overweight and obese adults is affected by weight loss program.

Authors:  Ana Petelin; Mojca Bizjak; Maša Černelič-Bizjak; Mihaela Jurdana; Tadeja Jakus; Zala Jenko-Pražnikar
Journal:  J Endocrinol Invest       Date:  2014-06-10       Impact factor: 4.256

10.  Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study.

Authors:  Kim Bouillon; Archana Singh-Manoux; Markus Jokela; Martin J Shipley; G David Batty; Eric J Brunner; Séverine Sabia; Adam G Tabák; Tasnime Akbaraly; Jane E Ferrie; Mika Kivimäki
Journal:  Heart       Date:  2011-04-12       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.